Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 21.60B | 22.02B | 21.20B | 21.25B | 20.53B | 21.14B |
Gross Profit | 21.60B | 22.47B | 21.20B | 21.77B | 20.30B | 20.41B |
EBITDA | 1.84B | 790.00M | 2.72B | 3.33B | 3.21B | 2.64B |
Net Income | 862.00M | 861.00M | 1.25B | 1.60B | 1.61B | 877.00M |
Balance Sheet | ||||||
Total Assets | 1.15T | 1.15T | 1.14T | 1.19T | 1.21T | 1.24T |
Cash, Cash Equivalents and Short-Term Investments | 95.76B | 95.76B | 64.52B | 108.97B | 128.42B | 160.63B |
Total Debt | 54.46B | 54.46B | 43.34B | 66.05B | 102.52B | 105.81B |
Total Liabilities | 1.10T | 1.10T | 1.08T | 1.11T | 1.14T | 1.17T |
Stockholders Equity | 50.70B | 50.70B | 58.65B | 73.77B | 71.32B | 72.55B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 9.13B | -7.23B | -32.97B | -35.05B | 79.31B |
Operating Cash Flow | 0.00 | 9.37B | -5.77B | -31.98B | -34.28B | 80.49B |
Investing Cash Flow | 0.00 | 6.28B | -5.94B | 6.11B | 2.49B | -513.00M |
Financing Cash Flow | 0.00 | 2.90B | -17.96B | 6.35B | -462.00M | 74.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥10.14B | 7.15 | 4.01% | 2.44% | 10.20% | ||
73 Outperform | ¥12.19B | 6.94 | 1.10% | 2.20% | ― | ||
72 Outperform | ¥12.89B | 11.15 | 3.68% | 7.67% | -26.27% | ||
68 Neutral | $17.80B | 11.94 | 9.89% | 3.74% | 9.69% | 1.17% | |
65 Neutral | ¥9.39B | 25.08 | 2.70% | 3.73% | -78.83% | ||
61 Neutral | ¥9.14B | 8.74 | 2.99% | -9.75% | 81.65% | ||
57 Neutral | ¥8.58B | ― | 2.02% | 2.60% | -246.98% |